Wells Fargo & Company Axonics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Axonics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 42,192 shares of AXNX stock, worth $2.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,192

Previous 36,471 15.69%

Holding current value

$2.94 Million

Previous $2.52 Million 12.76%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$66.47 - $69.65 $380,274 - $398,467	5,721 Added 15.69%	42,192 $2.84 Million
Q1 2024 May 10, 2024	SELL	$56.67 - $69.36 $617,249 - $755,469	-10,892 Reduced 23.0%	36,471 $2.52 Million
Q4 2023 Feb 09, 2024	BUY	$49.38 - $63.75 $164,386 - $212,223	3,329 Added 7.56%	47,363 $2.95 Million
Q3 2023 Nov 13, 2023	SELL	$48.64 - $62.51 $286,927 - $368,746	-5,899 Reduced 11.81%	44,034 $2.47 Million
Q2 2023 Aug 15, 2023	BUY	$47.99 - $60.21 $897,796 - $1.13 Million	18,708 Added 59.91%	49,933 $2.52 Million
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $493,019 - $631,177	9,373 Added 42.89%	31,225 $1.7 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $261,051 - $335,737	4,383 Added 25.09%	21,852 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $336,863 - $454,033	5,812 Added 49.86%	17,469 $1.23 Million
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $5.19 Million - $8.46 Million	-131,268 Reduced 91.84%	11,657 $661,000
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $775,641 - $1.11 Million	-17,733 Reduced 11.04%	142,925 $8.95 Million
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $20.6 Million - $30.1 Million	-410,923 Reduced 71.89%	160,658 $9 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $24.6 Million - $32.6 Million	414,679 Added 264.29%	571,581 $37.2 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $4.66 Million - $6.07 Million	90,683 Added 136.94%	156,902 $9.95 Million
Q1 2021 May 13, 2021	SELL	$49.14 - $59.89 $1.59 Million - $1.94 Million	-32,399 Reduced 32.85%	66,219 $3.97 Million
Q4 2020 Feb 09, 2021	BUY	$42.19 - $51.5 $1.78 Million - $2.18 Million	42,303 Added 75.12%	98,618 $4.92 Million
Q3 2020 Nov 05, 2020	BUY	$35.33 - $51.04 $289,670 - $418,476	8,199 Added 17.04%	56,315 $2.87 Million
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $5,223 - $9,081	228 Added 0.48%	48,116 $1.69 Million
Q1 2020 May 14, 2020	BUY	$16.44 - $37.73 $787,278 - $1.81 Million	47,888 New	47,888 $1.22 Million

Others Institutions Holding AXNX

# of Institutions

241

Shares Held

42.8M

Call Options Held

73.7K

Put Options Held

230K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.42B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Axonics, Inc. Transaction History